Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery-Reference-Cited by-同舟云学术

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery

Published:2013-06-19 Issue:11 Volume:40 Page:1718-1729
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Kijanka Marta,Warnders Frank-Jan,El Khattabi Mohamed,Lub-de Hooge Marjolijn,van Dam Gooitzen M.,Ntziachristos Vasilis,de Vries Liesbeth,Oliveira Sabrina,van Bergen en Henegouwen Paul M. P.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-013-2471-2.pdf

Reference29 articles.

1. Capala J, Bouchelouche K. Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’ strategy. Curr Opin Oncol 2010;22:559–66.

2. Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 1998;16:413–28.

3. Andreopoulou E, Hortobagyi GN. Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy. J Clin Oncol 2008;26:3660–2.

4. Allison M. The HER2 testing conundrum. Nat Biotechnol 2010;28:117–9.

5. Moelans CB, de Weger RA, Van der Wall E, van Diest PJ. Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol 2011;80:380–92.

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into the role and targeting of EGFRvIII;Structure;2024-09

2. Epidermal Growth Factor Receptor (EGFR) Inhibitors Screened from Autodisplayed Fv-Antibody Library;Bioconjugate Chemistry;2024-08-28

3. Single domain antibody: Development and application in biotechnology and biopharma;Immunological Reviews;2024-08-21

4. Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment;Nature Communications;2024-08-13

5. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies;Life Sciences;2024-05